Human Legumain PharmaGenie ELISA Kit (SBRS0828)

Legumain (LGMN), the lysosomal asparaginyl endopeptidase implicated in tumor invasion, antigen processing, and extracellular matrix remodeling, can be quantified in research samples using the Assay Genie Human Legumain PharmaGenie ELISA Kit. This 96-determination immunoassay is specific to the human protease and accepts matrices derived from cultured cell supernatant, plasma, and serum, supporting in vitro workflows in oncology, immunology, and drug discovery research.

Investigators studying tumor microenvironment proteases, antigen presentation pathways, or screening pharmaceutical compounds that modulate Legumain expression can run the assay on a standard microplate, with readouts compatible with conventional ELISA plate readers. The kit is intended for research use only and is not validated for other species.

Reagents should be refrigerated upon arrival and protected from light to preserve activity through the stated shelf life. Each kit is supplied as a complete configuration containing components sufficient for 96 individual wells in microplate format.